G49108TO
| Organisms | Evidence |
|---|---|
| Streptococcus pneumoniae | |
| Mus musculus (house mouse) | |
| Saccharomyces cerevisiae (brewer's yeast) | |
| Sus scrofa (pig) | |
| Rattus norvegicus (Norway rat) |
| Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
|---|---|---|---|---|---|---|
| B4GALT5 | (not applicable) |
|
[beta]-S-pNP |
|
[beta]-S-pNP | |
| B4GALT1 | UDP-Gal |
|
R |
|
R | |
| B4GALT2 | UDP-Gal |
|
Benzyl-[beta] |
|
Benzyl-[beta] | |
| B3GALT2 | UDP-Gal |
|
Lemieux |
|
Lemieux | |
| B3GALT5 | UDP-Gal |
|
R |
|
R |
| Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
|---|---|---|---|---|---|---|
| B4GALT5 | UDP-Gal |
|
|
|||
| B4GALT3 | UDP-Gal |
|
Benzyl-[beta] |
|
Benzyl-[beta] | |
| B4GALT4 | UDP-Gal |
|
[beta]-1-Benzl |
|
[beta]-1-Benzl | |
| B4GALT3 | UDP-Gal |
|
p-Nitrophenyl-1-thio-[beta] |
|
p-Nitrophenyl-1-thio-[beta] | |
| B4GALT2 | UDP-Gal |
|
[beta]-S-pNP |
|
[beta]-S-pNP |
| UniProt ID | Protein Name | Reference | Source |
|---|---|---|---|
| A0A1B0GSG7 | Kinesin-like protein | ||
| A0A1B0GUY1 | MARCO-like protein | ||
| A0A1B0GW35 | Exocyst complex component 1-like | ||
| A0A1B0GX95 | T cell receptor beta variable 7-4 | ||
| A0A1P8BET4 | Uncharacterized protein | ||
| A0A1Q1NIF8 | non-specific serine/threonine protein kinase | ||
| A0A286YF58 | Transmembrane protein 271 | ||
| A0A4P7NM30 | RNA polymerase II degradation factor 1 | ||
| A0A571BE33 | von Willebrand factor A domain containing 3B | ||
| A0A5A6 | T cell receptor beta variable 11-3 |
| Pathway Name | Organism |
|---|---|
| Antimicrobial peptides | Sus scrofa |
| Antimicrobial peptides | Rattus norvegicus |
| Antimicrobial peptides | Dictyostelium discoideum |
| Antimicrobial peptides | Bos taurus |
| Antimicrobial peptides | Canis familiaris |
| Antimicrobial peptides | Mus musculus |
| Antimicrobial peptides | Gallus gallus |
| Antimicrobial peptides | Homo sapiens |
| Antimicrobial peptides | Drosophila melanogaster |
| Antimicrobial peptides | Xenopus tropicalis |
RES 1b:b-dglc-HEX-1:5 2s:n-acetyl LIN 1:1d(2+1)2n
| PubMed ID | Title | First Author | Publication Date | Source |
|---|---|---|---|---|
| 37443315 | Cryo-EM Structures of Full-length Integrin alphaIIbbeta3 in Native Lipids complexed with Eptifibatide | Adair B | 2023 Jul 26 |
|
| 37453062 | Systematic analysis of the impact of phosphorylation and O-GlcNAcylation on protein subcellular localization | Xu S | 2023 Jul 25 |
|
| 37471688 | C-2 Thiophenyl Tryptophan Trimers Inhibit Cellular Entry of SARS-CoV-2 through Interaction with the Viral Spike (S) Protein | Gargantilla M | 2023 Jul 20 |
|
| 37474494 | A maize epimerase modulates cell wall synthesis and glycosylation during stomatal morphogenesis | Zhou Y | 2023 Jul 20 |
|
| 37468498 | A preclinical secondary pharmacology resource illuminates target-adverse drug reaction associations of marketed drugs | Sutherland JJ | 2023 Jul 19 |
|
| 37463923 | Conformational trajectory of allosteric gating of the human cone photoreceptor cyclic nucleotide-gated channel | Hu Z | 2023 Jul 18 |
|
| 37169147 | d-Glucosamine induces circadian phase delay by promoting BMAL1 degradation through AMPK/mTOR pathway | Li Z | 2023 Jul 15 |
|
| 37452031 | Structural delineation and computational design of SARS-CoV-2-neutralizing antibodies against Omicron subvariants | Moriyama S | 2023 Jul 14 |
|
| 37279852 | O-GlcNAcylation in cancer development and immunotherapy | He XF | 2023 Jul 10 |
|
| 37428845 | 3D structures of the Plasmodium vivax subtilisin-like drug target SUB1 reveal conformational changes to accommodate a substrate-derived α-ketoamide inhibitor | Martinez M | 2023 Jul 10 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.4.0
Last updated: December 8, 2025